HIF-1α induces multidrug resistance in gastric cancer cells by inducing miR-27a

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Zhao, Qun ^a   Li, Yong ^a   Tan, Bi Bo ^a   Fan, Li Qiao ^a   Yang, Pei Gang ^a   Tian, Yuan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MICRORNA; MICRORNA 27A; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; MIRN27 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER RESISTANCE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TRANSCRIPTION REGULATION; WESTERN BLOTTING; CELL PROLIFERATION; DRUG RESISTANCE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MIDDLE AGED; PROCEDURES; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICRORNAS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84943141524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132746     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108. PMID: 15761078
2. Roukos DH. (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol. 16(4):795-798. doi: 10.1245/s10434-009-0317-8 PMID: 19169753
3. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. (2013) An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol. 43(5):492-507. doi: 10.1093/jjco/hyt038 PMID: 23493744
4. Naito Y, Uchiyama K, Kinoshita Y, Fukudo S, Joh T, Suzuki H, et al. (2012) A questionnaire-based survey on screening for gastric and colorectal cancer by physicians in East Asian countries in 2010. Digestion. 86(2):94-106. doi: 10.1159/000339342 PMID: 22846219
5. Gravalos C, Jimeno A. (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 19(9):1523-1529. doi: 10.1093/annonc/mdn169 PMID: 18441328
6. D'Ugo D, Rausei S, Biondi A, Persiani R. (2009) Preoperative treatment and surgery in gastric cancer: friends or foes? Lancet Oncol. 10(2):191-195. doi: 10.1016/S1470-2045 (09) 70021-X PMID: 19185837
7. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van De Velde CJ, Nicolson M, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 6; 355(1):11-20. PMID: 16822992
8. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 345(10):725-730. PMID: 11547741
9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. (2011) Global cancer statistics. CA Cancer J Clin. 61(2):69-90. doi: 10.3322/caac.20107 PMID: 21296855
10. Li Y, Tan BB, Fan LQ, Zhao Q, Liu Y, Wang D. (2012) Heterogeneity of COX-2 and multidrug resistance between primary tumors and regional lymph node metastases of gastric cancer. Tumori. 98(4):516-522. doi: 10.1700/1146.12648 PMID: 23052170
11. Sun F, Lu X, Li H, Peng Z, Wu K, Wang G, et al. (2012) Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells. Oncol Lett. 4(1):156-162. PMID: 22807980
12. Chen CT, Kim H, Liska D, Gao S, Christensen JG, Weiser MR. (2012) MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. Mol Cancer Ther. 11(3):660-669. doi: 10.1158/1535-7163. MCT-11-0754 PMID: 22238368
13. Cheng JC, Klausen C, Leung PC. (2013) Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett. 329(2):197-206. doi: 10.1016/j.canlet.2012.10.029 PMID: 23142284
14. Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. (2012) SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 487(7407):380-384. doi: 10.1038/nature11207 PMID: 22801492
15. Liu W, Shen SM, Zhao XY, Chen GQ. (2012) Targeted genes and interacting proteins of hypoxia inducible factor-1. Int J Biochem Mol Biol, 3(2):165-178. PMID: 22773957
16. Zhu H, Luo SF, Wang J, Li X, Wang H, Pu WY, et al. (2012) Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1β. Chin Med J (Engl). 125(6):1095-1103.
17. Min L, Chen Q, He S, Liu S, Ma Y. (2012) Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1β expression. Mol Med Report. 5(1):228-232.
18. Zhao X, Yang L, Hu J. (2011) Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Cancer Res. 13; 30:55. doi: 10.1186/1756-9966-30-55 PMID: 21569481
19. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. (2008) A microRNA component of the hypoxic response. Cell Death Differ. 15(4):667-671. doi: 10.1038/sj.cdd.4402310 PMID: 18219318
20. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M. (1996) Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis. 14(1):43-54. PMID: 8521616
21. Wang C, Han M, Zhao XM, Wen JK. (2008) Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J Biochem. 144(3):313-321. doi: 10.1093/jb/mvn068 PMID: 18511453
22. Kamangar F, Dores GM, Anderson WF. (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 24(14):2137-2150. PMID: 16682732
23. Pereira KM, Chaves FN, Viana TS, Carvalho FS, Costa FW, Alves AP, et al. (2013) Oxygen metabolism in oral cancer: HIF and GLUTs. Oncol Lett. 6(2):311-316. PMID: 24137322
24. Miyake S, Kitajima Y, Nakamura J, Kai K, Yanagihara K, Tanaka T, et al. (2013) HIF-1β is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. Int J Oncol. 43(5):1431-1440. doi: 10.3892/ijo.2013.2068 PMID: 23970191
25. Wei H, Li F, Fu P, Liu X. (2013) Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. Eur Rev Med Pharmacol Sci. 17(4):436-446. PMID: 23467940
26. Carbajo-Pescador S, Ordonez R, Benet M, Jover R, Garcia-Palomo A, Mauriz JL, et al. (2013) Inhibition of VEGF expression through blockade of Hif1β and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer. 109(1):83-91. doi: 10.1038/bjc.2013.285 PMID: 23756865
27. Sermeus A, Genin M, Maincent A, Fransolet M, Notte A, Leclere L, et al. (2012) Hypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell types. PLoS One. 7(11):e47519. doi: 10.1371/journal.pone.0047519 PMID: 23139748
28. Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H, et al. (2012) The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis. 33(11):2250-2259. doi: 10.1093/carcin/bgs249 PMID: 22831955
29. Li DW, Dong P, Wang F, Chen XW, Xu CZ, Zhou L. (2013) Hypoxia Induced Multidrug Resistance of Laryngeal Cancer Cells via Hypoxia-inducible Factor-1β. Asian Pac J Cancer Prev. 14(8):4853-4858. PMID: 24083758
30. Tong Y, Li QG, Xing TY, Zhang M, Zhang JJ, Xia Q. (2013) HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells. FEBS Lett. 587(16):2530-2535. doi: 10.1016/j.febslet.2013.06.017 PMID: 23792163
31. Liu Y, Bernauer AM, Yingling CM, Belinsky SA. (2012) HIF1β regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis. 33(6):1187-1192. doi: 10.1093/carcin/bgs142 PMID: 22467238
32. Nakamura J, Kitajima Y, Kai K, Mitsuno M, Ide T, Hashiguchi K, et al. (2009) Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer. Oncol Rep. 22(4):693-699. PMID: 19724845
33. Hannon GJ. (2002) RNA interference. Nature. 418(6894):244-251. PMID: 12110901
34. Sandhu S, Garzon R. (2011) Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment. Semin Oncol. 38(6):781-787. doi: 10.1053/j.seminoncol.2011.08.007 PMID: 22082764
35. Xu K, Liang X, Cui D, Wu Y, Shi W, Liu J. (2013) miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells. Mol Carcinog. 52(1):70-78. doi: 10.1002/mc.21832 PMID: 22121083
36. Li ZM, Hu S, Xiao L, Wang J, Cai J, Yu LL, et al. (2010) Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells. Zhonghua Fu Chan Ke Za Zhi. 45(5):372-375. PMID: 20646448